{"schema_version":"secwatch.filing_event.v1","accession":"0001159036-26-000106","form_type":"8-K","ticker":"HALO","cik":"0001159036","company_name":"HALOZYME THERAPEUTICS, INC.","filed_at":"2026-08-18T20:04:09+00:00","discovered_at":"2026-08-18T20:05:01.465373+00:00","generated_at":"2026-08-18T20:05:06.878746+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Halozyme elects Dannielle Appelhans to board of directors","bullets":["Dannielle Appelhans elected to Halozyme board on Aug 14, 2026, class with term ending at 2028 annual meeting.","No initial committee assignment; will receive standard non-employee director compensation (cash, RSUs, options).","No arrangements or related-person transactions disclosed in connection with her election."],"urls":{"canonical":"https://secwatch.observer/filing/0001159036-26-000106","json":"https://secwatch.observer/filing/0001159036-26-000106.json","markdown":"https://secwatch.observer/filing/0001159036-26-000106.md","text":"https://secwatch.observer/filing/0001159036-26-000106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000106/0001159036-26-000106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000106/halo-20260814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-18T20:05:06.878746+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}